Selected article for: "academia industry and low middle income countries"

Author: Baay, Marc; Lina, Bruno; Fontanet, Arnaud; Marchant, Arnaud; Saville, Melanie; Sabot, Philippe; Duclos, Philippe; Vandeputte, Joris; Neels, Pieter
Title: SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
  • Cord-id: 5nv88wgj
  • Document date: 2020_6_23
  • ID: 5nv88wgj
    Snippet: This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.
    Document: This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • adaptive innate and low mortality: 1
    • adaptive innate and lower respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • adaptive innate and lymphocyte count: 1, 2
    • adaptive innate and lymphocyte depletion: 1
    • adaptive innate and lymphocyte recruitment: 1, 2
    • adaptive innate and macrophage differentiate: 1
    • ade antibody dependent enhancement and long term protection: 1
    • ade antibody dependent enhancement and low infectivity: 1